Changes in the DNA of cells cause cancer. Cancer genomics identifies genetic changes, defines molecular subtypes, and develops precision medicine techniques for cancer treatment using technologies such as sequencing. Genome sequencing is providing physicians greater information about the causes of cancer and modifying how some cancers are treated. Genomic assays allow for the identification of somatic and germline abnormalities in individual tumor samples, are becoming more widely employed in clinical diagnostics as a means of determining therapeutic alternatives. Genomic-based tests are increasingly being used as part of evidence-based diagnosis to help patients with cancer get better care.
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Revolutionizing psychological care in oncology: A comprehensive review of emerging technologies and their impact on cancer patients
Manijeh Firoozi, University of Tehran, Iran (Islamic Republic of)
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : A systematic review of medical art therapy for cancer patients
Manijeh Firoozi, University of Tehran, Iran (Islamic Republic of)
Title : Effect of heterosteroids derived from sapogenin in PI3K/AKT/mTOR and apoptosis pathways in breast cancer cells
Nadia Leney Olazo Marquez, Benemérita Universidad Autónoma de Puebla, Mexico
Title : In search of common path in cancerous point mutations
Ratan Kumar Sarkar, Independent Researcher, India